Additional information Active substance Semaglutide Formula C187H291N45O59 Side effects Nausea, vomiting, diarrhea, abdominal pain, decreased appetite Effects Improved glycemic control, weight loss Dosage (sports) Not recommended for use in sports Dosage (medical) 0.25 mg once weekly, increasing to 0.5 mg and up to 1 mg as tolerated and needed Half-life Approximately 1 week Main action Lowers blood glucose levels Substance class GLP-1 receptor agonist Chemical name Semaglutide Storage conditions Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) Trade name Ozempic, Rybelsus Blood pressure Can cause a reduction in blood pressure Also known as N/A Lab Test Blood glucose levels, HbA1c Hepatotoxicity Low risk Water Retention Minimal Use in sports None, not indicated for performance enhancement Manufacturer Beligas Pharmaceuticals Packing 5 mg (1 prefilled pen)
